GoodRx Holdings, Inc. — Form SCHEDULE 13D/A
Filed August 26, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
Francisco Partners IV, L.P. filed an amended Schedule 13D/A regarding its beneficial ownership in GoodRx Holdings, Inc. The filing is dated August 26, 2026. The document itself contains no specific share count, percentage ownership, dollar amounts, or substantive details about what changed from the prior disclosure—only the filing header and administrative information are visible.
Why this rating
Amendment to existing 13D filing with no disclosed changes in ownership stakes, transactions, or material facts. Routine regulatory disclosure update.
See more from August 26, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.